The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials
about
Development of lacosamide for the treatment of partial-onset seizuresSodium channel slow inactivation as a therapeutic target for myotonia congenitaEfficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.Safe Treatment of Seizures in the Setting of HIV/AIDS.The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experienceThe adverse event profile of perampanel: meta-analysis of randomized controlled trials.The long-term safety of antiepileptic drugs.Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.A systematic review of placebo-controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug?Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability.Tolerability of new antiepileptic drugs: a network meta-analysis.Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation.Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood.Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures.Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus.
P2860
Q24629140-BF1E0647-02BD-4508-90AF-236EA5D25EE6Q35044306-7F158677-D03A-432B-A30D-5F9079A687E0Q37057835-120BF506-DAD3-498D-8242-2F616233C456Q37096562-5245931F-DE04-43B5-8545-0E359E79EB28Q37722778-A3F4874F-FEB7-436D-94C3-7EFCE0C68978Q38100835-A9722061-A7BD-4AE4-88C3-581E9FD6ACFAQ38106856-1C336279-F0B9-4914-9347-ED24DD38B387Q38199973-59ED7ABC-621E-4887-819B-15AEADF57F85Q38259757-C35BF080-9CE4-4F48-B041-A021DC4BB017Q38617833-E0811460-F92A-4402-9F8D-FD4705CF1F7EQ38667878-9AF53F8E-C868-48F8-8E0F-549387ADB617Q38871987-A7C3D637-3562-4984-B405-40984220E3A1Q39220757-7B716EAC-24A1-40DD-89CE-DDB761E82502Q39624169-42EAAB04-B08F-44CB-A2BC-D0FA49BC554EQ41433754-7AE056CB-6BFB-49AB-BEE8-CE78A830B670Q48020465-7B976F3B-254D-4184-BCAE-1B4FEDDB8DD0Q50599628-1E77D2B9-89D4-49D1-BA8B-C030715BD579Q53750305-EFFFC08B-41C3-4A0A-9432-4CE8EFEDC480
P2860
The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The adverse event profile of l ...... f randomized controlled trials
@ast
The adverse event profile of l ...... f randomized controlled trials
@en
The adverse event profile of l ...... f randomized controlled trials
@nl
type
label
The adverse event profile of l ...... f randomized controlled trials
@ast
The adverse event profile of l ...... f randomized controlled trials
@en
The adverse event profile of l ...... f randomized controlled trials
@nl
prefLabel
The adverse event profile of l ...... f randomized controlled trials
@ast
The adverse event profile of l ...... f randomized controlled trials
@en
The adverse event profile of l ...... f randomized controlled trials
@nl
P2093
P2860
P31
P3181
P1433
P1476
The adverse event profile of l ...... f randomized controlled trials
@en
P2093
Alberto Verrotti
Fabio Giovannelli
Gaetano Zaccara
Giulia Loiacono
P2860
P3181
P356
10.1111/J.1528-1167.2012.03589.X
P407
P577
2012-07-10T00:00:00Z